You're signed outSign in or to get full access.
Kryger Capital LTD
Kryger Capital Limited is a London-based alternative investment fund manager authorised and regulated by the Financial Conduct Authority (FCA), with additional SEC ERA registration and Bermuda licensing. Founded in 2020, the firm manages several funds and provides investment management services to professional clients and eligible counterparties, focusing on fund management activities. Kryger Capital operates with about 10 employees and serves institutional and professional investors globally.
Investment Strategy
Kryger Capital employs an active investment approach, managing multiple funds with significant allocations to sectors such as industrials, consumer discretionary, and healthcare. Their portfolio turnover is high (over 70% per quarter), suggesting a dynamic trading strategy targeting alpha generation through frequent position adjustments, fundamental analysis, and tactical exposures. Recent top holdings include Hess Corporation, AZEK Company, and Frontier Communications, with rapid repositioning to capitalize on emerging market opportunities. The firm emphasizes deep research and flexible reallocation to maximize returns for professional investors.
Latest 13F Filing Activity
Kryger Capital LTD filed their most recent 13F report on Jun 30, 2025 disclosing 16 equity positions with a total 13F market value of $540M. The fund increased holdings in Azek Company CL A Ord, Skechers USA CL A Ord, Springworks Therapeutics Ord among other positions. Kryger Capital LTD reduced exposure to Berry Global Group Inc., Intra-cellular Therapies, Discover Financial Services among others.
Top Holdings
Equity Positions (16)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
H HES | HESS ORD | 26.48% | $143.1M | 1,033,178 | $147.75 | $138.54 | -$20.2M |
A AZEK | AZEK COMPANY CL A ORD | 19.75% | $106.7M | 1,967,510 | $53.22 | $54.35 | +$86.9M |
F FYBR | FRONTIER COMMUNICATIONS PARENT ORD | 12.66% | $68.4M | 1,879,772 | $35.67 | $36.40 | -$2.9M |
S SKX | SKECHERS USA CL A ORD | 9.22% | $49.8M | 789,579 | $63.10 | $63.10 | +$49.8M |
S SWTX | SPRINGWORKS THERAPEUTICS ORD | 6.66% | $36.0M | 765,522 | $46.68 | $46.99 | +$32.4M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more